If this eight-steroid approach is similar in cost to more minimalist approaches, then the additional information obtained could be beneficial. If, on the other hand, the cost is eight times that of a single (perhaps direct) assay, it would be difficult to support this approach for routine baseline testing. However, as stated earlier, in patients suspected of having an adrenal enzymatic deficiency, or who may have been found to have an elevated value for early morning 17a-hydroxyprogesterone, this comprehensive assessment before and after ACTH may be warranted.
Such patients may prove to be the group for whom this new test is most appropriate.
